Dr. Max Klement is a Principal at Novo Holdings who has more than 10 years of experience working in biotechnology and life science venture investments. Most recently, he was Principal at BioGeneration Ventures, a European life science venture capital firm with more than €250 million under management.

Prior to that, Max was part of the founding team at Hummingbird Bioscience and has held various operational roles in the biotechnology space.

Max obtained his PhD in biochemical engineering from the National University of Singapore as an A*STAR Fellow and an MBA from INSEAD.